Adipocytokines and risk of stroke in older people: A nested case - Control study

International Journal of Epidemiology

Volumn 38, Issue 1, 2009, Pages 253-261

  Stott, David J ^a,c   Welsh, Paul ^a   Rumley, Ann ^a   Robertson, Michele ^a   Ford, Ian ^a   Sattar, Naveed ^a   Westendorp, Rudi G J ^b   Jukema, J Wouter ^b   Cobbe, Stuart M ^a   Lowe, Gordon D O ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adiponectin; Aged; Case Control study; Inflammation; Interleukin 18; Stroke; Tumour necrosis factor

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INTERLEUKIN 18; PLACEBO; PRAVASTATIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

DISABILITY; ELDERLY POPULATION; HEALTH RISK; MULTIVARIATE ANALYSIS; STROKE;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BARTHEL INDEX; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOKINES; ADIPONECTIN; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; EUROPE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-18; MALE; MYOCARDIAL INFARCTION; RECURRENCE; RISK FACTORS; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60149084187     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyn215     Document Type: Article

References (42)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
2. Ishikawa M, Vowinkel T, Stokes KY et al. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/ reperfusion. Circulation 2005;111: 1690-96.
3. Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
4. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipo-protein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557-65.
5. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. Meta-analyses of propective studies. JAMA 1998;279 1477-82.
6. Danesh J, Lewington S, Thompson SG et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294 1799-809.
7. Welsh P, Lowe GD, Chalmers C et al. Associations of proinflammatory cytokines with risk of recurrent stroke. Stroke 2008;39:2226-30.
8. Matsumoto M, Ishikawa S, Kajii E. Association of adiponectin with cerebrovascular disease: A nested case-control study. Stroke 2008;39:323-28.
9. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diab Obes Metab 2007;9:282-89.
10. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005;36:1915-19.
11. Mallat Z, Corbaz A, Scoazec A et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104: 1598-603.
12. Zaremba J, Losy J. Interleukin-18 in acute ischaemic stroke patients. Neurol Sci 2003;24:117-24.
13. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101 2149-53.
14. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med 2002;8:1363-68.
15. Zaremba J, Losy J. Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 2001;104: 288-95.
16. Karaduman M, Sengul A, Oktenli C et al. Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Clin Endocrinol 2006;64 196-202.
17. Woodward M, Rumley A, Lowe GD, Tunstall-Pedoe H. C-reactive protein: associations with haematological. variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haemat 2003;122 135-41.
18. Shepherd J, Blauw GJ, Murphy MB et al., on behalf of the PROSPER Study Group Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002; 360:1623-30.
19. Shepherd J, Blauw GJ, Murphy MB et al., on behalf of the PROSPER Study Group. A prospective study of Pravastatin in the elderly at risk (PROSPER): The design. Am J Cardiol 1999;84:1192-97.
20. Iglseder B, Mackevics V, Stadimayer A, Tasch G, Ladurner G, Paulweber B. Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: Data from the SAPHIR Study. Stroke 2005;36:2577-82.
21. Thorand B, Kolb H, Baumert J et al. Elevated levels of interleukin- 18 predict the development of type 2 diabetes: Results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 2005;54 2932-38.
22. Bretz WA, Weyant RJ, Corby PM et al. Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population: J Am Geriatr Soc 2005;53:1532-37.
23. Woodward M, Lowe GD, Campbell DJ et al. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 2005;36:2143-47.
24. Isobe T, Saitoh S, Takagi S et al. Influence of gender, age and renal function on plasma adiponectin level: The Tanno and Sobetsu study. Eur J Endocrinol 2005; 153:91-98.
25. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma' adiponectin concentration in apparently healthy males and females. Clin Endocrinol 2005;62:114-18.
26. Vilarrasa N, Vendrell J, Maravall J et al. Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Clin Endocrinol 2005;63:329-35.
27. Bik W, Baranowska-Bik A, Wolinska-Witort E et al. The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuroendocrinol Lett 2006;27 493-500.
28. McEntegart MB, Awede B, Petrie MC et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines' and B-type natriuretic peptide. Eur Heart J 2007;28:829-35.
29. Sattar N, Wannamethee G, Sarwar N et al. Adiponectin and coronary heart disease: A prospective study and meta-analysis. Circulation 2006;114:623-29.
30. Blankenberg S, Luc G, Ducimetiere P et al., PRIME Study Group. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003;108:2453-59.
31. Blankenberg S, Tiret L, Bickel C et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002;106:24-30.
32. Blankenberg S, McQueen MJ, Smieja M et al. Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2006; 114:201-8.
33. Koenig W, Khuseyinova N, Baumert J et al. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc. Biol 2006;26:2745-51.
34. Tiret L, Godefroy T, Lubos E et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005;112:643-50.
35. Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D. Advancing age and insulin resistance: New facts about an ancient history. Eur J Clin Invest 1999;29:758-69.
36. Cesari M, Penninx BW, Newman AB et al. Inflammatory markers and onset of cardiovascular events: Results from the Health ABC study. Circulation 2003;108: 2317-22.
37. Sacco RL. Risk factors for TIA and TIA as a risk factor for stroke. Neurology 2004;62 (8 Suppl 6):S7-11.
38. Kuller LH. Epidemiology and prevention of stroke, now and in the future. Epidemiol Rev 2000;22:14-17.
39. Reynolds K, Lewis LB, Nolen JDL, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: A meta-analysis. J Am Med Assoc 2003;289:579-88.
40. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-16.
41. Rodgers H, Greenaway J, Davies T, Wood R, Steen N, Thomson R. Risk factors for first-ever stroke in older people in the north East of England: A population-based study. Stroke 2004;35:7-11.
42. Kamper AM, Stott DJ, Hyland M, Murray HM, Ford I. Predictors of functional decline in elderly people with vascular risk factors or disease. Age Ageing 2005;34:444-49.